Credits
Tracy Swan was born in West Hollywood, California. She moved to New York City in 2001. In Sept 2003, she joined TAG's full-time staff as Coinfection Project Director. She is delighted to have the opportunity to bring together her experience in direct service, advocacy, education, program development, policy and research for TAG. She started her HIV/AIDS work in 1990, and HCV work in 1998. Ms. Swan has developed policies and curricula for HIV counseling and testing programs targeted towards GLBT youth and active drug users, created an HCV education and services program, and worked in a variety of venues, including community health centers, detoxification facilities, homeless shelters, methadone clinics, residential drug treatment programs, a syringe exchange program, and transitional housing facilities. She is the author of TAG's 2003 Research and Policy Recommendations for Hepatitis C Virus (HCV)/HIV Coinfection. Ms. Swan is a former member of the Community Constituency Group of the Adult AIDS Clinical Trials Group, where she served as the Community's Representative to the Liver Disease Subcommittee and the Immunology Research Agenda Committee. She is a member of the AIDS Treatment Activists Coalition's Drug Development Committee. Contact her at: tracyswan@verizon.net.

Daniel Raymond works as the Hepatitis C Policy Analyst for the Harm Reduction Coalition in New York City. More of his writings on HCV research and drug development can be found online at the Hepatitis C Harm Reduction Project weblog www.hepcproject.org. Contact him at: raymond@harmreduction.org.

The Treatment Action Group (TAG) fights to find a cure for AIDS and to ensure that all people living with HIV receive the necessary treatment, care, and information they need to save their lives TAG focuses on the AIDS research effort, both public and private, the drug development process, and our nation's health care delivery systems. We meet with researchers, industry, and government officials, and resort when necessary to acts of civil disobedience, or to acts of Congress. We strive to develop the scientific and political expertise needed to transform policy. TAG is committed to working for and with all communities affected by HIV.

If you would like more information about TAG, contact us at:

Treatment Action Group
611 Broadway, Suite 608
New York, NY 10012
P: 212.253.7922
F: 212.253.7923
www.treatmentactiongroup.org